ArticleMolecular and clinical oncology2023

Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.

Francesca Morgese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.